{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:21:51Z","timestamp":1740158511732,"version":"3.37.3"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008403","name":"Suomalainen L\u00e4\u00e4k\u00e4riseura Duodecim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003756","name":"Biomedicum Helsinki-s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ticks and Tick-borne Diseases"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ttbdis.2021.101854","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T12:36:11Z","timestamp":1634042171000},"page":"101854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Consumption of healthcare services and antibiotics in patients with presumed disseminated Lyme borreliosis before and after evaluation of an infectious disease specialist"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9843-8841","authenticated-orcid":false,"given":"Elisa","family":"Kortela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari J","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satu","family":"Kurkela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Oksi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asko","family":"J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ttbdis.2021.101854_bib0001","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/2374373517736385","article-title":"Motivations and experiences of Canadians seeking treatment for Lyme disease outside of the conventional Canadian health-care system","volume":"5","author":"Boudreau","year":"2018","journal-title":"J Patient Exp"},{"key":"10.1016\/j.ttbdis.2021.101854_bib0002","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of \"chronic Lyme disease","volume":"357","author":"Feder","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0003","first-page":"1568","article-title":"Adverse events associated with antibiotics and intravenous therapies for Post-Lyme Disease syndrome in a commercially insured sample","volume":"67","author":"Goodlet","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0004","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/cid\/ciy799","article-title":"Holistic approach in patients with presumed Lyme borreliosis leads to less than 10% of confirmation and more than 80% of antibiotic failures","volume":"68","author":"Haddad","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mus.10337","article-title":"Lyme disease and the peripheral nervous system","volume":"28","author":"Halperin","year":"2003","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.ttbdis.2021.101854_bib0006","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cmi.2020.09.022","article-title":"Suspicion of Lyme borreliosis in patients referred to an infectious diseases clinic: what did the patients really have?","volume":"27","author":"Kortela","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0007","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/cid\/ciaa217","article-title":"Oral doxycycline compared to intravenous ceftriaxone in the treatment of Lyme neuroborreliosis: a multicenter, equivalence, randomized, open-label trial","volume":"72","author":"Kortela","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0008","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial","volume":"7","author":"Lj\u00f8stad","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0009","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00415-017-8559-z","article-title":"Lyme neuroborreliosis: do we treat according to guidelines?","volume":"264","author":"Lorentzen","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/vbz.2010.0116","article-title":"Long-term Lyme disease antibiotic therapy beliefs among New England residents","volume":"11","author":"Macauda","year":"2011","journal-title":"Vector Borne Zoonotic Dis."},{"issue":"8\u201316","key":"10.1016\/j.ttbdis.2021.101854_bib0011","first-page":"e11","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0012","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","article-title":"The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans","volume":"100","author":"Nadelman","year":"1996","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0013","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-128-5-199803010-00003","article-title":"The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study","volume":"128","author":"Reid","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0014","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3201\/eid2308.161273","article-title":"Lyme Borreliosis in Finland, 1995-2014","volume":"23","author":"Sajanti","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0015","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(03)14798-8","article-title":"Lyme borreliosis","volume":"362","author":"Stanek","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ttbdis.2021.101854_bib0016","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ttbdis.2021.101854_bib0017","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM198908313210906","article-title":"Lyme disease","volume":"321","author":"Steere","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0018","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ttbdis.2021.101854_bib0019","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz1218","article-title":"Posttreatment symptoms in Lyme borreliosis","author":"Strle","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2021.101854_bib0020","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin. Infect. Dis."}],"container-title":["Ticks and Tick-borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X21002077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X21002077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T08:49:59Z","timestamp":1639471799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877959X21002077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1877959X21002077"],"URL":"https:\/\/doi.org\/10.1016\/j.ttbdis.2021.101854","relation":{},"ISSN":["1877-959X"],"issn-type":[{"type":"print","value":"1877-959X"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consumption of healthcare services and antibiotics in patients with presumed disseminated Lyme borreliosis before and after evaluation of an infectious disease specialist","name":"articletitle","label":"Article Title"},{"value":"Ticks and Tick-borne Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ttbdis.2021.101854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101854"}}